(Q35680206)

9 August 2017

1 reference

title

Bosentan: a novel agent for the treatment of pulmonary arterial hypertension (English)

1 reference

9 August 2017

Dermot O'Callaghan

1

1 reference

9 August 2017

Sean P Gaine

series ordinal

2

1 reference

9 August 2017

language of work or name

1 reference

1 January 2004

1 reference

International Journal of Clinical Practice

9 August 2017

published in

1 reference

9 August 2017

volume

58

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

69-73

1 reference

High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2004.0098.X

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2004.0098.X

Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2004.0098.X

Receptors for endothelin-1 in asthmatic human peripheral lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2004.0098.X

Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2004.0098.X

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2004.0098.X

The endothelin family of peptides: local hormones with diverse roles in health and disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1368-5031.2004.0098.X

10.1111/J.1368-5031.2004.0098.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference